Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative
A pharmaceutical composition for preventing or treating eye diseases and an oral administration agent for preventing or treating eye diseases are provided. The pharmaceutical composition for preventing or treating eye diseases comprises the compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient.
1. A method of treating intraocular pressure elevation or glaucoma in a subject in need thereof, comprising:
orally administering a pharmaceutical composition comprising an effective amount of a compound of the Chemical Formula A or a pharmaceutically acceptable salt thereof as an active ingredient to the subject,
wherein the effective amount is determined by a reduction in intraocular pressure at 22 days after administration.
2. The method of claim 1 , wherein the pharmaceutical composition further comprises an excipient comprising at least one selected from the group consisting of methyl cellulose (MC), dimethyl sulfoxide (DMSO), polyethylene glycol (PEG) and distilled water.
3. The method of claim 2 , wherein the excipient comprises 0.5 wt % of methyl cellulose.
4. The method of claim 1 , wherein the compound of the Chemical Formula A or the pharmaceutically acceptable salt thereof is filled in capsules in powder form.